Urinary prostaglandin E2 metabolite and gastric cancer risk in the Shanghai women's health study.
about
Urinary eicosanoid metabolites in HIV-infected women with central obesity switching to raltegravir: an analysis from the women, integrase, and fat accumulation trial.Urinary PGE-M levels are associated with risk of colorectal adenomas and chemopreventive response to anti-inflammatory drugs.Intra-person variation of urinary biomarkers of oxidative stress and inflammationRole of inflammation and inflammatory mediators in colorectal cancerA review of the application of inflammatory biomarkers in epidemiologic cancer research.Fruit and vegetable consumption and risk of distal gastric cancer in the Shanghai Women's and Men's Health studies.Urinary PGE-M in colorectal cancer: predicting more than risk?Urinary prostaglandin E2 metabolite and pancreatic cancer risk: case-control study in urban ShanghaiUrinary prostaglandin E2 metabolite and risk for colorectal adenoma.PPARδ and PGE2 signaling pathways communicate and connect inflammation to colorectal cancerUrine Eicosanoids in the Metabolic Abnormalities, Telmisartan, and HIV Infection (MATH) Trial.Prospective cohort study of tea consumption and risk of digestive system cancers: results from the Shanghai Women's Health Study.Prostaglandin E2 Promotes Colorectal Cancer Stem Cell Expansion and Metastasis in Mice.Fruit and vegetable intake and urinary levels of prostaglandin E₂ metabolite in postmenopausal women.An inflammatory mediator, prostaglandin E2, in colorectal cancer.The endothelial lipase protein is promising urinary biomarker for diagnosis of gastric cancer.Association between urinary prostaglandin E2 metabolite and breast cancer risk: a prospective, case-cohort study of postmenopausal women.The Crosstalk of PTGS2 and EGF Signaling Pathways in Colorectal CancerSex differences in urinary biomarkers of vascular and endothelial function in HIV-infected persons receiving antiretroviral therapyUrinary PGE-M: a promising cancer biomarkerASPirin Intervention for the REDuction of colorectal cancer risk (ASPIRED): a study protocol for a randomized controlled trial.Prospective study of urinary prostaglandin E2 metabolite and pancreatic cancer risk.A Prospective Study of Urinary Prostaglandin E2 Metabolite, Helicobacter pylori Antibodies, and Gastric Cancer Risk.Urinary levels of prostaglandin E2 are positively correlated with intratumoral infiltration of Foxp3+ regulatory T cells in non-small cell lung cancer.Circulating prostaglandins as biomarkers for colorectal cancer?Impact of celecoxib on inflammation during cancer surgery: a randomized clinical trial.Simultaneous LC-MS/MS analysis of eicosanoids and related metabolites in human serum, sputum and BALF.A ultra-pressure liquid chromatography/triple quadrupole tandem mass spectrometry method for the analysis of 13 eicosanoids in human urine and quantitative 24 hour values in healthy volunteers in a controlled constant diet
P2860
Q33759853-CA3D018A-A511-4D82-A0D5-8D2E4428C066Q33857191-D3ED932C-FDB3-4A1A-BA0F-4E0F6D9A3F3FQ33866985-8BF76CC1-8B87-41AC-808B-D7DB22603930Q33957824-C68FD9F0-ABE1-4939-9C36-D89B52426695Q34135803-E9956F88-9A01-4F3C-AEA1-7AB3E9A81041Q34179440-6FE3F033-2A72-45EF-828B-753CDC0B99B5Q34289285-841B784E-AF78-422E-B4CD-881E94867E32Q35094999-186E79BF-191A-49FE-96C3-E46879C55907Q35740134-54C0CEBA-7564-414B-9558-55DFC1015648Q35963300-53EBC6B5-F77B-45AB-9C29-2D41E905A711Q36258777-FDA15C44-9F33-43F6-AD65-999037C383A6Q36317080-99EB4C5D-0400-4CCC-B00C-D38E24322FFCQ36604053-5D4ACAA6-245C-4B3E-B4A0-DD37152BA87BQ36654662-58BB9E2C-944F-4F7B-8790-718142380C2AQ36701908-366CE0E3-9AC1-416C-A124-8039FFF7EFC9Q36752744-7A0AD53C-15B2-4676-930C-11E72CDCD37FQ36916609-3DA1E440-B4EE-41AE-8B3D-4A0290145B63Q37148157-5646EA38-FAEC-4FDE-A89E-CA1D5AF03BCCQ37155953-DC61CCD0-DC3F-4CD9-BD19-FAD90CBDCCF4Q37166867-081FDA9C-49C9-495E-AE22-222113A5DA21Q37618698-3657D036-60AD-400D-B02B-1C2E8C0A5578Q40080359-2E5F2C35-25A7-43C7-A282-B203742E3971Q40246172-10792D77-9417-4718-AFDE-ED1532A75061Q41142487-43BF0DBF-25E5-40A1-8BA9-3EC65519C4ACQ41624931-21A3BC5B-B19D-4971-A635-C01E9D20790AQ47341907-71FD4C32-9905-4564-89CF-D7F5D24E9A39Q47678157-90DED0EC-6573-49E9-98B6-7C0BA6EB0A2EQ57715709-6F2CBFEF-FCF4-4BDA-B2B6-4D38F66B6B3A
P2860
Urinary prostaglandin E2 metabolite and gastric cancer risk in the Shanghai women's health study.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 27 October 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Urinary prostaglandin E2 metab ...... Shanghai women's health study.
@en
Urinary prostaglandin E2 metab ...... Shanghai women's health study.
@nl
type
label
Urinary prostaglandin E2 metab ...... Shanghai women's health study.
@en
Urinary prostaglandin E2 metab ...... Shanghai women's health study.
@nl
prefLabel
Urinary prostaglandin E2 metab ...... Shanghai women's health study.
@en
Urinary prostaglandin E2 metab ...... Shanghai women's health study.
@nl
P2093
P2860
P50
P1476
Urinary prostaglandin E2 metab ...... Shanghai women's health study.
@en
P2093
Bu-Tian Ji
Hong-Lan Li
Linda M Dong
Wong-Ho Chow
P2860
P304
P356
10.1158/1055-9965.EPI-09-0680
P577
2009-10-27T00:00:00Z